We found that among patients with diabetes aged 66 and older, the incidence of nAMD was approximately 1 in 1,000 in those who had never used GLP-1 receptor agonists, compared to about 2 in 1,000 among those who had been exposed to these medications for at least six months, Muni said
doi:10.1007/s00223-020-00720-4 Abo-Elenin MHH, Kamel R, Nofal S, Ahmed AAE
BMJ Open 8(12):e024262
If youre exploring whether a GLP-1 may be right for your goals and circumstances, a short assessment can help clarify your options and next steps before moving forward.
GLP-1 medications are commonly prescribed under the brand names of Ozempic, Wegovy, Mounjaro, Trulicity, and Zepbound
Wegovy (semaglutide) injection 1.7 mg or 2.4 mg and Wegovy (semaglutide) tablets 25 mg are prescription medicines used with a reduced calorie diet and increased physical activity to: reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight
